Singh SK - Search Results

1

Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome.

Chaturvedi S, Rashid M, Malik MY, Agarwal A, Singh SK, Gayen JR, Wahajuddin M. Chaturvedi S, et al. Among authors: singh sk. Drug Discov Today. 2019 May;24(5):1166-1175. doi: 10.1016/j.drudis.2019.02.007. Epub 2019 Mar 18. Drug Discov Today. 2019. PMID: 30898661 Review.

2

Pharmacokinetics and bioavailability assessment of Miltefosine in rats using high performance liquid chromatography tandem mass spectrometry.

Valicherla GR, Tripathi P, Singh SK, Syed AA, Riyazuddin M, Husain A, Javia D, Italiya KS, Mishra PR, Gayen JR. Valicherla GR, et al. Among authors: singh sk. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 15;1031:123-130. doi: 10.1016/j.jchromb.2016.07.042. Epub 2016 Jul 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 27475453

3

Phospholipid complexation of NMITLI118RT+: way to a prudent therapeutic approach for beneficial outcomes in ischemic stroke in rats.

Ahmad H, Arya A, Agrawal S, Samuel SS, Singh SK, Valicherla GR, Sangwan N, Mitra K, Gayen JR, Paliwal S, Shukla R, Dwivedi AK. Ahmad H, et al. Among authors: singh sk. Drug Deliv. 2016 Nov;23(9):3606-3618. doi: 10.1080/10717544.2016.1212950. Epub 2016 Aug 12. Drug Deliv. 2016. PMID: 27685355

4

Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.

Singh SK, Makadia V, Sharma S, Rashid M, Shahi S, Mishra PR, Wahajuddin M, Gayen JR. Singh SK, et al. Drug Deliv Transl Res. 2017 Jun;7(3):395-407. doi: 10.1007/s13346-017-0362-y. Drug Deliv Transl Res. 2017. PMID: 28194730

5

Species differences between rat and human in vitro metabolite profile, in vivo predicted clearance, CYP450 inhibition and CYP450 isoforms that metabolize benzanthrone: Implications in risk assessment.

Taneja I, Karsauliya K, Rashid M, Sonkar AK, Rama Raju KS, Singh SK, Das M, Wahajuddin M, Singh SP. Taneja I, et al. Among authors: singh sp, singh sk. Food Chem Toxicol. 2018 Jan;111:94-101. doi: 10.1016/j.fct.2017.11.009. Epub 2017 Nov 7. Food Chem Toxicol. 2018. PMID: 29126801

6

Development and validation of UPLC-MS/MS assay for quantification of cladrin: Absolute bioavailability and dose proportionality study in rats.

Rashid M, Singh SK, Malik MY, Jahan S, Chaturvedi S, Taneja I, Raju KS, Naseem Z, Gayen JR, Wahajuddin M. Rashid M, et al. Among authors: singh sk. J Pharm Biomed Anal. 2018 Apr 15;152:289-297. doi: 10.1016/j.jpba.2018.01.044. Epub 2018 Jan 31. J Pharm Biomed Anal. 2018. PMID: 29454264

7

Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents.

Ghoshal A, Kumar A, Yugandhar D, Sona C, Kuriakose S, Nagesh K, Rashid M, Singh SK, Wahajuddin M, Yadav PN, Srivastava AK. Ghoshal A, et al. Among authors: singh sk. Eur J Med Chem. 2018 May 25;152:148-159. doi: 10.1016/j.ejmech.2018.04.020. Epub 2018 Apr 26. Eur J Med Chem. 2018. PMID: 29704723

8

Evaluation of oral pharmacokinetics, in vitro metabolism, blood partitioning and plasma protein binding of novel antidiabetic agent, S009-0629 in rats.

Valicherla GR, Italiya KS, Gupta CP, Mishra S, Riyazuddin M, Syed AA, Singh SK, Shahi S, Taneja G, Wahajuddin M, Goel A, Gayen JR. Valicherla GR, et al. Among authors: singh sk. Drug Dev Res. 2018 Jun;79(4):173-183. doi: 10.1002/ddr.21433. Drug Dev Res. 2018. PMID: 29989222

9

Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].

Ghoshal A, Kumar A, Yugandhar D, Sona C, Kuriakose S, Nagesh K, Rashid M, Singh SK, Wahajuddin M, Yadav PN, Srivastava AK. Ghoshal A, et al. Among authors: singh sk. Eur J Med Chem. 2018 Aug 5;156:628-630. doi: 10.1016/j.ejmech.2018.07.034. Epub 2018 Jul 19. Eur J Med Chem. 2018. PMID: 30031973 No abstract available.

10

Determination of permeability, plasma protein binding, blood partitioning, pharmacokinetics and tissue distribution of Withanolide A in rats: A neuroprotective steroidal lactone.

Singh SK, Valicherla GR, Joshi P, Shahi S, Syed AA, Gupta AP, Hossain Z, Italiya K, Makadia V, Singh SK, Wahajuddin M, Gayen JR. Singh SK, et al. Drug Dev Res. 2018 Nov;79(7):339-351. doi: 10.1002/ddr.21463. Epub 2018 Oct 4. Drug Dev Res. 2018. PMID: 30284738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,514 results

Search Page